David A Holdford
Overview
Explore the profile of David A Holdford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sisson E, Pamulapati L, Bucheit J, Zimmerman K, Dixon D, Holdford D, et al.
Curr Pharm Teach Learn
. 2024 Apr;
16(6):445-452.
PMID: 38631946
Background And Purpose: Effective communication skills are essential for all pharmacists, regardless of practice setting. An implicit need in pharmacy education is to emphasize direct application of these skills to...
2.
Pontinha V, Patterson J, Dixon D, Carroll N, Mays D, Barnes A, et al.
Res Social Adm Pharm
. 2024 Jan;
20(3):363-371.
PMID: 38176956
Background: It is thought that half of the patients with chronic conditions are not adherent to their medications, which contributes to significant health and economic burden. Many studies estimate medication...
3.
Jay J, Patterson J, Zhang Y, Ijioma S, Carroll N, Holdford D, et al.
J Am Pharm Assoc (2003)
. 2023 Jul;
63(6):1700-1705.e4.
PMID: 37414279
Background: Trials describing 4-12 week courses of direct-acting antiviral drugs (DAAs) to treat hepatitis C virus (HCV) transmission from infected donors to uninfected kidney transplant recipients (D+/R-transplants), may be limited...
4.
Ngo P, Bajaj S, Hincapie A, Gallo T, Clauson K, Holdford D, et al.
Curr Pharm Teach Learn
. 2022 Apr;
14(4):415-424.
PMID: 35483806
Introduction: Health care is trending towards an increasing reliance on data management, technology, analytics, and automation which is also reflected in pharmacy education. This study aimed to identify and characterize...
5.
Jay J, Ijioma S, Holdford D, Dixon D, Sisson E, Patterson J
J Manag Care Spec Pharm
. 2021 Nov;
27(12):1680-1690.
PMID: 34818090
Hypertension is highly prevalent in the United States, affecting nearly half of all adults (43%). Studies have shown that pharmacist-physician collaborative care models (PPCCMs) for hypertension management significantly improve blood...
6.
Holdford D, Pontinha V, Wagner T
Am J Pharm Educ
. 2021 Aug;
86(3):8719.
PMID: 34385177
To review the use of the business model canvas, a one-page visual description of a business initiative, as a tool for teaching pharmacy students about entrepreneurship and business planning in...
7.
Holdford D
Pharm Pract (Granada)
. 2021 Jun;
19(2):2430.
PMID: 34188731
Clarity about the pharmacist's "product" is fundamental to developing and communicating the value of pharmacy offerings. It is clear within the profession that pharmacists use their scope of knowledge and...
8.
Ijioma S, Pontinha V, Holdford D, Carroll N
J Manag Care Spec Pharm
. 2021 Jan;
27(2):137-146.
PMID: 33506729
The hepatitis C virus (HCV) prevalence rate among injection drug users (IDUs) in North America is 55.2%, with 1.41 million individuals estimated to be HCV-antibody positive. Studies have shown the...
9.
Pontinha V, Wagner T, Holdford D
J Am Pharm Assoc (2003)
. 2020 Dec;
61(2):e45-e54.
PMID: 33309067
Background: Point-of-care tests (POCTs) are innovative services that are increasingly offered in community pharmacies. Assessments of these services should consider their financial sustainability in addition to their effectiveness if they...
10.
Salgado T, Reynolds T, Frankart L, Holdford D, DiPiro J
Pharm Pract (Granada)
. 2020 Dec;
18(4):2120.
PMID: 33294062
Objective: The Outcomes and Assessment Committee at the Virginia Commonwealth University School of Pharmacy was tasked with refining the school's key performance indicators (KPIs) to improve programmatic assessment by focusing...